Search results
BioNTech (NASDAQ:BNTX) Receives “Buy” Rating from HC Wainwright
ETF DAILY NEWS· 7 days agoHC Wainwright reissued their buy rating on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Monday, Benzinga reports. The brokerage currently has a $113.00 ...
Kansas AG sues Pfizer over 'misleading' COVID-19 vaccine claims
FOX 23 Maine· 5 hours agoKansas Attorney General Kris Kobach announced Monday he is suing pharmaceutical giant Pfizer for...
Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best
Insider Monkey via Yahoo Finance· 5 hours agoRGA Investment Advisors, an investment management company released its first quarter 2024 investor...
Gateway - Quartz
Quartz· 56 minutes agoIs the covid pandemic over? The World Health Organization (WHO) is set to consider that question at a meeting this week, its 14th since the UN agency first identified the coronavirus outbreak ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 6 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 7 days agoModerna representatives told news outlets that the company aspires to have the new shot approved by...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 3 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
